Page last updated: 2024-10-21

2-aminoethoxydiphenyl borate and Arthritis, Rheumatoid

2-aminoethoxydiphenyl borate has been researched along with Arthritis, Rheumatoid in 1 studies

2-aminoethoxydiphenyl borate: is a novel membrane-penetrable modulator and transient receptor potential channel blocker; structure in first source; do not confuse with 2-APB cpd
2-aminoethoxydiphenylborane : An organoboron compound that is diphenylborane in which the borane hydrogen is replaced by a 2-aminoethoxy group.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, X2
Wang, X1
Wang, Y1
Huang, C1
Li, J1

Other Studies

1 other study available for 2-aminoethoxydiphenyl borate and Arthritis, Rheumatoid

ArticleYear
Inhibition of transient receptor potential melastatin 7 (TRPM7) channel induces RA FLSs apoptosis through endoplasmic reticulum (ER) stress.
    Clinical rheumatology, 2014, Volume: 33, Issue:11

    Topics: Animals; Apoptosis; Arthritis, Rheumatoid; Boron Compounds; Calpain; Caspase 3; Disease Models, Anim

2014